Lupin Ltd. (LUPIN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 641789,
    "name": "Lupin",
    "stock_name": "Lupin",
    "full_name": "Lupin Ltd.",
    "name_url": "stocks-analysis/lupin",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,342.15",
    "chg": -25.65,
    "chgp": "-1.08%",
    "dir": -1,
    "prev_price": "2,367.80",
    "mcapval": "108,357.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 500257,
    "symbol": "LUPIN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE326A01037",
    "curr_date": "Jun 25, 03:30 PM",
    "curr_time": "21:20 PM",
    "last_traded_at": "Jun 25, 03:30 PM IST",
    "bse_nse_vol": "3.36 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 25, 2026",
    "traded_date_str": "2026 06 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lupin-641789-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MN",
      "url": "https://www.marketsmojo.com/mojopro/strategy/2",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lupin-641789-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Lupin Ltd. Sees Significant Open Interest Surge Signalling Bullish Market Positioning",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-significant-open-interest-surge-signalling-bullish-market-positioning-4070713",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/LupinLtd_oi_spurts_by_underlying_4070713.png",
        "date": "2026-06-24 15:00:34",
        "description": "Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling increased investor interest and potential directional bets. The stock’s recent performance, combined with rising volumes and improved market positioning, suggests a bullish sentiment among traders and investors alike."
      },
      {
        "title": "Lupin Ltd. Sees Significant Open Interest Surge Amid Bullish Market Positioning",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-significant-open-interest-surge-amid-bullish-market-positioning-4070629",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/LupinLtd_oi_spurts_by_underlying_4070629.png",
        "date": "2026-06-24 14:00:32",
        "description": "Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling increased investor interest and potential directional bets. The stock’s recent performance, combined with rising volumes and improved market positioning, suggests a cautiously optimistic outlook among traders and investors alike."
      },
      {
        "title": "Lupin Ltd. Sees Significant Open Interest Surge Amid Bullish Market Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-significant-open-interest-surge-amid-bullish-market-momentum-4070547",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/LupinLtd_oi_spurts_by_underlying_4070547.png",
        "date": "2026-06-24 13:00:15",
        "description": "Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling increased investor interest and potential directional bets. The stock’s recent outperformance, coupled with rising volumes and improved market positioning, suggests a bullish sentiment among traders and investors alike."
      },
      {
        "title": "Lupin Ltd. is Rated Buy by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lupin-ltd-is-rated-buy-by-marketsmojo-4062956",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/LupinLtd_mojoScore_4062956.png",
        "date": "2026-06-19 10:11:29",
        "description": "Lupin Ltd. is rated 'Buy' by MarketsMOJO, with this rating last updated on 25 May 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 19 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Lupin Ltd. Sees Significant Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-significant-open-interest-surge-amid-mixed-market-signals-4038383",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/LupinLtd_oi_spurts_by_underlying_4038383.png",
        "date": "2026-06-08 11:00:10",
        "description": "Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.3% increase in open interest (OI) in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite a modest price decline of 0.54% on 8 June 2026, the surge in OI alongside volume patterns suggests a complex interplay of directional bets and market sentiment."
      },
      {
        "title": "Lupin Ltd. is Rated Buy by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lupin-ltd-is-rated-buy-by-marketsmojo-4036681",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/LupinLtd_mojoScore_4036681.png",
        "date": "2026-06-08 10:10:57",
        "description": "Lupin Ltd. is rated 'Buy' by MarketsMOJO, with this rating last updated on 25 May 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock's current position as of 08 June 2026, providing investors with the latest insights into the company's performance and outlook."
      },
      {
        "title": "Lupin Ltd. is Rated Buy by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lupin-ltd-is-rated-buy-by-marketsmojo-4036723",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/LupinLtd_mojoScore_4036723.png",
        "date": "2026-06-07 10:10:47",
        "description": "Lupin Ltd. is rated 'Buy' by MarketsMOJO, with this rating last updated on 25 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Lupin Ltd. is Rated Buy by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lupin-ltd-is-rated-buy-by-marketsmojo-4036837",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/LupinLtd_mojoScore_4036837.png",
        "date": "2026-06-06 10:10:48",
        "description": "Lupin Ltd. is rated 'Buy' by MarketsMOJO, with this rating last updated on 25 May 2026. While the rating adjustment occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 08 June 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "Lupin Ltd. Valuation Shifts Signal Attractive Investment Opportunity Amid Sector Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-valuation-shifts-signal-attractive-investment-opportunity-amid-sector-dynamics-4025273",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/LupinLtd_valuationdot_4025273.png",
        "date": "2026-06-01 08:03:52",
        "description": "Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from a very attractive to an attractive rating. This recalibration reflects evolving market perceptions amid robust financial metrics and competitive peer comparisons, offering investors a nuanced perspective on the stock’s price attractiveness and growth potential."
      }
    ],
    "total": 692,
    "sid": "641789",
    "stock_news_url": "https://www.marketsmojo.com/news/lupin-641789"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "22-Jun-2026",
      "details": "Intimation regarding Grant of 1567591 Stock Option under Lupin Employees Stock Option Scheme 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "17-Jun-2026",
      "details": "Lupin Launches Azilsartan Medoxomil Tablets in the United States.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "08-Jun-2026",
      "details": "Lupin Collaborates with ERN for Luforbec (beclometasone/formoterol) pMDI Launch in Spain.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has declared <strong>600%</strong> dividend, ex-date: 25 Jul 25",
          "dt": "2025-07-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has announced <strong>2:10</strong> stock split, ex-date: 27 Aug 10",
          "dt": "2010-08-27",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 11 Aug 06",
          "dt": "2006-08-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Lupin Ltd. Sees Significant Open Interest Surge Signalling Bullish Market Positioning

2026-06-24 15:00:34

Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling increased investor interest and potential directional bets. The stock’s recent performance, combined with rising volumes and improved market positioning, suggests a bullish sentiment among traders and investors alike.

Read full news article

Lupin Ltd. Sees Significant Open Interest Surge Amid Bullish Market Positioning

2026-06-24 14:00:32

Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling increased investor interest and potential directional bets. The stock’s recent performance, combined with rising volumes and improved market positioning, suggests a cautiously optimistic outlook among traders and investors alike.

Read full news article

Lupin Ltd. Sees Significant Open Interest Surge Amid Bullish Market Momentum

2026-06-24 13:00:15

Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling increased investor interest and potential directional bets. The stock’s recent outperformance, coupled with rising volumes and improved market positioning, suggests a bullish sentiment among traders and investors alike.

Read full news article

Lupin Ltd. is Rated Buy by MarketsMOJO

2026-06-19 10:11:29

Lupin Ltd. is rated 'Buy' by MarketsMOJO, with this rating last updated on 25 May 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 19 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Lupin Ltd. Sees Significant Open Interest Surge Amid Mixed Market Signals

2026-06-08 11:00:10

Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.3% increase in open interest (OI) in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite a modest price decline of 0.54% on 8 June 2026, the surge in OI alongside volume patterns suggests a complex interplay of directional bets and market sentiment.

Read full news article

Lupin Ltd. is Rated Buy by MarketsMOJO

2026-06-08 10:10:57

Lupin Ltd. is rated 'Buy' by MarketsMOJO, with this rating last updated on 25 May 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock's current position as of 08 June 2026, providing investors with the latest insights into the company's performance and outlook.

Read full news article

Lupin Ltd. is Rated Buy by MarketsMOJO

2026-06-07 10:10:47

Lupin Ltd. is rated 'Buy' by MarketsMOJO, with this rating last updated on 25 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Lupin Ltd. is Rated Buy by MarketsMOJO

2026-06-06 10:10:48

Lupin Ltd. is rated 'Buy' by MarketsMOJO, with this rating last updated on 25 May 2026. While the rating adjustment occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 08 June 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Read full news article

Lupin Ltd. Valuation Shifts Signal Attractive Investment Opportunity Amid Sector Dynamics

2026-06-01 08:03:52

Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its valuation parameters, moving from a very attractive to an attractive rating. This recalibration reflects evolving market perceptions amid robust financial metrics and competitive peer comparisons, offering investors a nuanced perspective on the stock’s price attractiveness and growth potential.

Read full news article

View All News